Table 1.
The differential metabolites identified by volcano plot analysis and significance analysis of microarrays in patients with laryngeal cancer compared with healthy individuals.
| No | Parameters | HC mean ± SD | LC mean ± SD | Status | P value | FDR |
| 1 | Cit/Arg | 6.4291 ± 5.0526 | 3.6705 ± 3.9508 | ↓ | .0000 | 0.0000 |
| 2 | Pro | 522.9987 ± 193.8309 | 385.9781 ± 230.5362 | ↓ | .0011 | 0.0073 |
| 3 | Arg | 5.3577 ± 4.6369 | 13.2538 ± 12.5404 | ↑ | .0000 | 0.0000 |
| 4 | C26 | 0.0260 ± 0.0129 | 0.0382 ± 0.0151 | ↑ | .0000 | 0.0000 |
| 5 | C26/C20 | 0.4836 ± 0.3341 | 0.8939 ± 0.6750 | ↑ | .0000 | 0.0000 |
| 6 | C3DC | 0.0349 ± 0.0212 | 0.0891 ± 0.0666 | ↑ | .0000 | 0.0000 |
| 7 | C18:1 | 0.4009 ± 0.1281 | 0.6203 ± 0.2561 | ↑ | .0000 | 0.0000 |
| 8 | C18:1-OH | 0.0013 ± 0.0059 | 0.0190 ± 0.0265 | ↑ | .0000 | 0.0000 |
| 9 | C10:1 | 0.0647 ± 0.0507 | 0.1262 ± 0.0804 | ↑ | .0000 | 0.0000 |
| 10 | C3DC/C10 | 0.3868 ± 0.3153 | 0.8158 ± 0.7225 | ↑ | .0002 | 0.0019 |
| 11 | C14:2 | 0.2817 ± 0.2496 | 0.5383 ± 0.3591 | ↑ | .0002 | 0.0019 |
| 12 | C2/C0 | 0.2809 ± 0.1092 | 0.3998 ± 0.1868 | ↑ | .0008 | 0.0057 |
| 13 | Orn | 23.2502 ± 7.8453 | 36.6597 ± 22.3176 | ↑ | .0036 | 0.0196 |
| 14 | C2 | 8.6304 ± 3.0170 | 11.6971 ± 5.9515 | ↑ | .0039 | 0.0196 |
| 15 | Orn/Cit | 1.2032 ± 0.6647 | 1.8182 ± 1.1898 | ↑ | .0052 | 0.0242 |
| 16 | C3/Met | 0.0560 ± 0.0254 | 0.0891 ± 0.0591 | ↑ | .0076 | 0.0337 |
Arg = arginine, C0 = free carnitine, C10:1 = decenoylcarnitine, C10 = decanoylcarnitine, C14:2 = tetradecadienoylcarnitine, C18:1 = oleylcarnitine, C18:1-OH = 3-hydroxy-octadecenoylcarnitine, C2 = acetylcarnitine, C20 = arachidic carnitine, C26 = hexacosanoic carnitine, C3 = propionylcarnitine, C3DC = malonylcarnitine, Cit = citrulline, HC = healthy control, LC = laryngeal cancer, Met = methionine, Orn = ornithine, Pro = proline.